| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |